Central venous catheters (CVC) have revolutionized the care of patients requiring long-term
venous access. With increasing use of CVCs, the incidence of catheter-related thrombosis …

This article about antithrombotic therapy in children is part of the 7th American College of
Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based …

Background Neonates and children differ from adults in physiology, pharmacologic
responses to drugs, epidemiology, and long-term consequences of thrombosis. This …

The American Heart Association recognizes the importance of physically active lifestyles to
the health and well-being of children and adults with congenital heart defects. Counseling of …

Thrombosis has long been recognized as a potentially lifethreatening complication in
children with congenital heart disease (CHD), children with acquired heart disease, and in …

This chapter about antithrombotic therapy in neonates and children is part of the
Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence …

Objectives: The purpose of this study was to compare the safety and efficacy of
acetylsalicylic acid (ASA) and warfarin for thromboprophylaxis after the Fontan procedure …

Many medicines prescribed for children are unlicensed. Solid dosage forms present
problems as children have difficulty swallowing whole tablets or capsules. When medicines …

Venous thrombo‐embolism (VTE) is increasingly recognized in paediatric practice. Few
clinical trials have been performed in this area in children and management is largely …

Venous thrombosis (VTE) in children and neonates presents numerous management
challenges. Although increasing in frequency, VTE in children and neonates is still …